BioPharma

The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals that are participating in the 340B drugs discount program. The pilot happens to depart from the...

President Donald Trump of the USA has sent letters to the drug company CEOs demanding they lower their drug prices. The letters that have been posted by Trump on social media Say name-brand drug prices are almost three times...

In a recent move, an international initiative is going to transform biologics as well as drug manufacturing by way of AI-driven multi-platform integration. The AI-optimized BALANCE (Bioreactor automation for learning and adaptive networked control of experiments) platform is going...

Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms Permira and Nordic Capital. Apparently, the board of directors of the company plan to unanimously...

The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of almost $8 billion in 2025 year-to-date. It has emerged as a biopharma innovation hub...

The head of the Food and Drug Administration office, overseeing vaccines and gene therapy, Vinay Prasad leaves the FDA after taking over his job just three months before. Department of Health and Human Services spokesperson, Andrew Nixon, confirmed his departure...

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs...